News
A Common Weight Loss Drug Can Treat Severe Liver Disease, F.D.A. Says
The Food and Drug Administration approved the weight loss drug Wegovy to treat an increasingly prevalent liver disease on Friday. Roughly 15 million people — six percent of adults in the United States — have metabolic dysfunction-associated steatohepatitis, known as MASH. Rates of the disease are rising.
A series of panels convened by the Food and Drug Administration is raising concerns that the agency is skirting federal rules ...
Lead is toxic to people of any age or health status and higher exposure levels can lead to neurological changes ...
The U.S. Food and Drug Administration has approved Tonix Pharmaceuticals' drug to manage pain related to a type of chronic ...
The initiative is a response to a Trump administration order to speed the construction of the type of new drug factories many ...
5don MSN
More than 20 GOP attorneys general call on RFK Jr, FDA to reinstate safeguards for abortion drugs
More than 20 Republican attorneys general are demanding that the Trump administration reinstate safety protocols for the ...
The FDA said in letters to five sunscreen makers that they are not authorized to market sunscreen sold in mousse or whipped form.
Families concerned about color additives in school lunches, at grocery stores and at fast-food counters can now reference a ...
The dessert dip was initially recalled by manufacturers in late July with its risk classification raising to a Class II ...
The FDA stated that consumers should check their home for these affected products and throw away any cookware that can leach lead into food. Do not donate or refurbish this cookware. Those who have ...
Scientists at Northwestern University have discovered a drug that could offer a new approach to treating life-threatening ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback